1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)Resectable Hepatocellular Carcinoma With High Risk of RecurrenceRecruitingNot stated2025-07-15NCT07064681